JARALIX

Live / Applied — Third extension granted (statement of use) (as of 05 Feb 2026)

What this means for you

Not registered yet, but its 13 Sept 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
98177753
Mark type
Stylized text
Filed
13 Sept 2023
Published for opposition
18 Jun 2024
Attorney of record
Vivian Ortiz-Ponce

Goods and services

  • Class 005 — Pharmaceuticals: Anti-tussive expectorants; Cough syrups for medical use; Pharmaceutical preparations for the treatment of respiratory disorders and diseases, for the treatment of cough and colds, for the treatment of upper respiratory tract infections; Pharmaceutical preparations for symptomatic relief of respiratory conditions, pediatric cough relief, adult cough relief, for the relief of colds and flu, for the relief of throat irritation; Pharmaceutical products for treating respiratory diseases; Pharmaceutical antitussive-cold preparations; Preparations for treating colds

Owner

Prosecution history

  • 05 Feb 2026 — SOU EXTENSION 3 GRANTED
  • 05 Feb 2026 — SOU EXTENSION 3 FILED
  • 05 Feb 2026 — SOU TEAS EXTENSION RECEIVED
  • 10 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 10 Aug 2025 — SOU EXTENSION 2 GRANTED
  • 10 Aug 2025 — SOU EXTENSION 2 FILED
  • 10 Aug 2025 — SOU TEAS EXTENSION RECEIVED
  • 05 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 04 Feb 2025 — SOU EXTENSION 1 GRANTED
  • 04 Feb 2025 — SOU EXTENSION 1 FILED
  • 04 Feb 2025 — SOU TEAS EXTENSION RECEIVED
  • 13 Aug 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 18 Jun 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 18 Jun 2024 — PUBLISHED FOR OPPOSITION
  • 29 May 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

View this trademark record on Marksy